US Patent Issued to 4SC on April 29 for "Combination comprising HDAC inhibitor and CD137 agonist for cancer therapy" (German Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,410, issued on April 29, was assigned to 4SC AG (Planegg-Martinsried, Germany).

"Combination comprising HDAC inhibitor and CD137 agonist for cancer therapy" was invented by Svetlana Hamm (Eichenau, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to medical uses of an HDAC inhibitor of the below general formula I, wherein R1 to R7 are as described herein, or a salt or solvate thereof in combination with a CD137 agonist for the treatment of cancer."

The patent was filed on March 26, 2019, under Application No. 17/041,703.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/n...